Delivery Order SPE2DB20D2104-SPE2DB23FR06G
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of the TWINRIX vaccine. The $1,806.60 firm fixed-price contract has a completion date of June 1, 2022 and was awarded on May 31, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $18,066.00 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for the supply of TWINRIX Vaccine Syringes. The contract has an ultimate completion date of June 16, 2022 and was awarded on June 15, 2022. Amerisourcebergen is a major pharmaceutical distributor that supports federal healthcare programs, particularly within the Department of Defense and Department of Veterans...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order issued by the Defense Logistics Agency (DLA) with a Firm Fixed Price of $2,870.14. The contract, which has no set-aside designation, is for the delivery of TWINRIX VACCINE SYRINGEML and has a completion date of March 17, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) was issued by the Defense Logistics Agency (DLA) for the delivery of Twinrix vaccine syringes. The $81,649.44 firm-fixed-price contract has a completion date of September 21, 2021. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides the Defense Logistics Agency (DLA) Troop Support Medical with a wide range of pharmaceutical products and medical supplies. The $2,215.85 Firm Fixed Price delivery order covers the delivery of Twinrix vaccine syringes. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which serves as the primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $177,856.40 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) for the supply of 4556976003 TWINRIX VACCINE SYRINGEML. The award has an ultimate completion date of April 25, 2022 and was made without any set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,199.16 firm-fixed-price delivery order is for the supply of Twinrix vaccine syringes. The award has an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide the Twinrix vaccine in syringe form. The contract has a ceiling value of $4,196.98 and a completion date of July 26, 2023. It is a firm-fixed-price delivery order contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through November 2026....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $155,412.62 firm fixed-price delivery order is for the supply of Twinrix vaccine syringes. The award is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $118,031.20 delivery order is for the supply of TWINRIX vaccine syringes. The contract is a Firm Fixed Price Delivery Order with a period of performance ending on July 26, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant $999,999,999...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FR06GDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,079.30 for the supply of the Twinrix vaccine. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of November 15, 2022. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/14/22 |